In focus · trending topic

#IMMUNOTHERAPY

4 stories · following the connections

Immune Therapeutics Clears Critical Regulatory Hurdle for Lodonal in Kenya

By Nasdaq OMXMar 17, 2017, 1:07 PM UTC

IMMUNE THERAPEUTICS STRENGTHENS BALANCE SHEET; Reiterates Outlook for Positive Cash Flow by Mid Year

By Nasdaq OMXFeb 9, 2017, 6:39 PM UTC

Immune Therapeutics Clears Critical Certification Milestone

By Nasdaq OMXFeb 2, 2017, 2:40 PM UTC

Immune Therapeutics Redeems $656,250 Convertible Note; Company Actively Working to Strengthen Balance Sheet by Year End

By Nasdaq OMXNov 15, 2016, 2:06 PM UTC